Abstract

Among the different mechanisms involved in oxidative stress, protein carbonylation and lipid peroxidation are both important modifications associated with the pathogenesis of several diseases, including cancer. Hematopoietic cells are particularly vulnerable to oxidative damage, as the excessive production of reactive oxygen species and associated lipid peroxidation suppress self-renewal and induce DNA damage and genomic instability, which can trigger malignancy. A richer understanding of the clinical effects of oxidative stress might improve the prognosis of these diseases and inform therapeutic strategies. The most common protein carbonylation and lipid peroxidation compounds, including hydroxynonenal, malondialdehyde, and advanced oxidation protein products, have been investigated for their potential effect on hematopoietic cells in several studies. In this review, we focus on the most important protein carbonylation and lipid peroxidation biomarkers in hematological malignancies, their role in disease development, and potential treatment implications.

Highlights

  • Oxidative stress can be defined as an imbalance between the production of reactive oxygen species (ROS) and the ability of the cells to detoxify them [1]

  • Lymphoma other than HL are covered by the general term non-Hodgkin lymphoma (NHL), which again comprises a heterogeneous group of B-cell and T-cell neoplasms [83,84]

  • Analysis of the lipid peroxidation products MDA and nitrite revealed significantly higher levels in patients with Myelodysplastic syndromes (MDS) and iron overload (IOL) compared with peers without IOL and the control group, and both parameters positively correlated with the levels of ferritin [41] (Figure 3)

Read more

Summary

Introduction

Oxidative stress can be defined as an imbalance between the production of reactive oxygen species (ROS) and the ability of the cells to detoxify them [1]. The indirect mechanism of protein carbonylation involves the carbonylation of lysine, cysteine, and histidine, which may be caused by their reaction with reactive carbonyl groups produced during the oxidation of carbohydrates (e.g., glyoxal (GO), methylglyoxal (MGO)) and lipids (e.g., HNE, MDA or acrolein (ACR)). This process of carbonyl generation is termed glycoxidation (the formation of advanced glycation end-products (AGEs)) and lipoxidation (the formation of ALEs), respectively [13,14,15,16,17,18]. We consider the experimental groups treated with 4 and 8 mg As2O3/kg body weight

Lymphoma
Hodgkin Lymphoma
Non-Hodgkin Lymphoma
Multiple Myeloma
Leukemia
Acute Lymphoblastic Leukemia
Chronic Lymphoblastic Leukemia
Acute Myeloid Leukemia
Chronic Myeloid Leukemia
Myelodysplastic Syndromes
Oxidative Stress Modulators for the Treatment of Hematological Malignancies
Potential Pro-Oxidant Drugs
Iron Chelators
Findings
Conclusions
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.